PPT-International Summit of Human Gene Editing

December 2 2015 Gary E Marchant PhD JD g arymarchantasuedu Human Gene Editing International Governance Arguments for International Governance International standards assure equal protection for citizens of all nations. Societal Implications of Emerging Technologies . . Continue . research on . somatic. . gene editing . with due oversight and ethical, social, and legal studies . Set . Moratorium. . on . basic research . Of Which People, By Which People, For Which People?. Charis Thompson. Chancellor’s Professor . UC Berkeley / London School . of Economics. Washington, DC, December 2015. Consensus on Human . Germline. Fyodor D. Urnov, PhD. Project Leader and Senior Scientist, Sangamo BioSciences, Inc.. NAS International . Summit on Human Gene . Editing. December 3, 2015. Genome Editing . Is. In the Clinic. Fyodor D. Urnov, PhD. Fyodor D. Urnov, PhD. Project Leader and Senior Scientist, Sangamo BioSciences, Inc.. NAS International . Summit on Human Gene . Editing. December 3, 2015. Genome Editing . Is. In the Clinic. Fyodor D. Urnov, PhD. . Prof. . Zhihong. Xu, . Peking . University & Chinese Academy of Sciences . Outline. Policy . and . National Regulation. Publications and . Funding. Suggestions from CAS and . Society. 2003. Ethics Guidelines of Human Embryonic Stem Cell Research. . Prof. . Zhihong. Xu, . Peking . University & Chinese Academy of Sciences . Outline. Policy . and . National Regulation. Publications and . Funding. Suggestions from CAS and . Society. 2003. Ethics Guidelines of Human Embryonic Stem Cell Research. December 2, 2015 . Gary E. Marchant, Ph.D., J.D. . g. ary.marchant@asu.edu. Human Gene Editing: International Governance. Arguments for International Governance. International standards assure equal protection for citizens of all nations. CRISPR Babies: Background and Ethics By: Austin Guse and Kaitlyn Curtis What is a CRISPR baby? An organism, specifically a human child, that has had its genetics altered in one way or another and has successfully been born or is still in guestation. Describe the Gene Editing Technology (CRISPR-Cas9, ZNF, TALENS, Meganucleases) . Describe . the target gene, function of the target gene. and . the desired effect of the target gene in the system (in-vitro/in vivo) . 12 – 13 November 2019, Singapore. www.gfbr.global.  .  .  .  . The GFBR. Funded by Bill & Melinda Gates Foundation, UK Medical Research Council, US National Institutes of Health, and . Wellcome. How can we advance CRISPR from a revolutionary research tool to a level of precision and efficiency that will enable us to target ANY genetic disease?. DUAL OMNI™ . TECHNOLOGY PLATFORMS. Novel CRISPR Nuclease Discovery Platform. Propelled by the promise of faster, cheaper, and more accurate by CRISPR-Cas gene editing. For all of their ease and rapidity, cell or gene therapy. The generation of unintended DNA strand its niche w The Urgent Need for Collaborative Partnerships in Africa. Dr Gerald Michael Ssebunnya. AFRICA INSTITUTE FOR HUMAN DIGNITY. gms@humandignityafrica.com. . GFBR Meeting 2019, Singapore. 12. th. – 13. Ethics, governance and policy aspects of human genome editing research . . Maneesha S Inamdar. JNCASR, Bangalore. GFBR. 12-13 Nov 2019. Singapore. Maneesha S Inamdar. Professor and Chair. Molecular Biology and Genetic Unit.